Tag Archives: Matthew Herder
Beware ‘Innovation-Speak’
Matthew Herder wrote a Master’s thesis on Canadian science policy some ten years ago and by the time he was done, he had sworn off the word ‘innovation.’
Enacting Pharmaceutical Transparency – Who, What, How, When, & Why
Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
Testing Canada’s New Pharmaceutical Transparency Law
Matthew Herder and Trudo Lemmens explore the ways that Canada’s transparency legislation may limit researchers’ abilities to scrutinize drug safety and effectiveness.
Pharma Financialized
Matthew Herder argues that recent drug price hikes are only one part of a bigger problem with industry-driven pharmaceutical research and development.
Impact Ethics 